BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 25797137)

  • 21. Analysis of specificity determinants in the interactions of different HPV E6 proteins with their PDZ domain-containing substrates.
    Thomas M; Dasgupta J; Zhang Y; Chen X; Banks L
    Virology; 2008 Jul; 376(2):371-8. PubMed ID: 18452965
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Restoration of MAGI-1 expression in human papillomavirus-positive tumor cells induces cell growth arrest and apoptosis.
    Kranjec C; Massimi P; Banks L
    J Virol; 2014 Jul; 88(13):7155-69. PubMed ID: 24696483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of papillomavirus E6 proteins with either MAML1 or E6AP clusters E6 proteins by structure, function, and evolutionary relatedness.
    Brimer N; Drews CM; Vande Pol SB
    PLoS Pathog; 2017 Dec; 13(12):e1006781. PubMed ID: 29281732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential localization of HPV16 E6 splice products with E6-associated protein.
    Vaeteewoottacharn K; Chamutpong S; Ponglikitmongkol M; Angeletti PC
    Virol J; 2005 Jun; 2():50. PubMed ID: 15960845
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Roles of the PDZ domain-binding motif of the human papillomavirus type 16 E6 on the immortalization and differentiation of primary human foreskin keratinocytes.
    Choi M; Lee S; Choi T; Lee C
    Virus Genes; 2014 Apr; 48(2):224-32. PubMed ID: 24293186
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The E2F5 repressor is an activator of E6/E7 transcription and of the S-phase entry in HPV18-associated cells.
    Teissier S; Pang CL; Thierry F
    Oncogene; 2010 Sep; 29(36):5061-70. PubMed ID: 20639900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HPV E6 degradation of p53 and PDZ containing substrates in an E6AP null background.
    Massimi P; Shai A; Lambert P; Banks L
    Oncogene; 2008 Mar; 27(12):1800-4. PubMed ID: 17934525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A systematic analysis of human papillomavirus (HPV) E6 PDZ substrates identifies MAGI-1 as a major target of HPV type 16 (HPV-16) and HPV-18 whose loss accompanies disruption of tight junctions.
    Kranjec C; Banks L
    J Virol; 2011 Feb; 85(4):1757-64. PubMed ID: 21123374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Specific recognition of four-way DNA junctions by the C-terminal zinc-binding domain of HPV oncoprotein E6.
    Ristriani T; Nominé Y; Masson M; Weiss E; Travé G
    J Mol Biol; 2001 Jan; 305(4):729-39. PubMed ID: 11162088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human papillomavirus type 16 E6 protein interacts with cystic fibrosis transmembrane regulator-associated ligand and promotes E6-associated protein-mediated ubiquitination and proteasomal degradation.
    Jeong KW; Kim HZ; Kim S; Kim YS; Choe J
    Oncogene; 2007 Jan; 26(4):487-99. PubMed ID: 16878151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Involvement of a cellular ubiquitin-protein ligase E6AP in the ubiquitin-mediated degradation of extensive substrates of high-risk human papillomavirus E6.
    Matsumoto Y; Nakagawa S; Yano T; Takizawa S; Nagasaka K; Nakagawa K; Minaguchi T; Wada O; Ooishi H; Matsumoto K; Yasugi T; Kanda T; Huibregtse JM; Taketani Y
    J Med Virol; 2006 Apr; 78(4):501-7. PubMed ID: 16482544
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of TMEM87B interacting with the human papillomavirus type 18 E6 oncogene in the Hela cDNA library by a yeast two-hybrid system.
    Li S; Liu P; Xi L; Jiang X; Wu M; Deng D; Wei J; Zhu T; Zhou L; Wang S; Xu G; Meng L; Zhou J; Ma D
    Oncol Rep; 2008 Aug; 20(2):421-7. PubMed ID: 18636207
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chimaeric HPV E6 proteins allow dissection of the proteolytic pathways regulating different E6 cellular target proteins.
    Pim D; Thomas M; Banks L
    Oncogene; 2002 Nov; 21(53):8140-8. PubMed ID: 12444549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The stability of the human papillomavirus E6 oncoprotein is E6AP dependent.
    Tomaić V; Pim D; Banks L
    Virology; 2009 Oct; 393(1):7-10. PubMed ID: 19700180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. E6 and E7 from human papillomavirus type 16 cooperate to target the PDZ protein Na/H exchange regulatory factor 1.
    Accardi R; Rubino R; Scalise M; Gheit T; Shahzad N; Thomas M; Banks L; Indiveri C; Sylla BS; Cardone RA; Reshkin SJ; Tommasino M
    J Virol; 2011 Aug; 85(16):8208-16. PubMed ID: 21680517
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The human papillomavirus (HPV) E6 oncoproteins promotes nuclear localization of active caspase 8.
    Manzo-Merino J; Massimi P; Lizano M; Banks L
    Virology; 2014 Feb; 450-451():146-52. PubMed ID: 24503077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-risk human papillomavirus E6 oncoproteins interact with 14-3-3ζ in a PDZ binding motif-dependent manner.
    Boon SS; Banks L
    J Virol; 2013 Feb; 87(3):1586-95. PubMed ID: 23175360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of cottontail rabbit papillomavirus E6 oncoproteins with the hDlg/SAP97 tumor suppressor.
    Du M; Fan X; Hanada T; Gao H; Lutchman M; Brandsma JL; Chishti AH; Chen JJ
    J Cell Biochem; 2005 Apr; 94(5):1038-45. PubMed ID: 15669058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PATJ, a tight junction-associated PDZ protein, is a novel degradation target of high-risk human papillomavirus E6 and the alternatively spliced isoform 18 E6.
    Storrs CH; Silverstein SJ
    J Virol; 2007 Apr; 81(8):4080-90. PubMed ID: 17287269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kinetic analysis of the interactions of human papillomavirus E6 oncoproteins with the ubiquitin ligase E6AP using surface plasmon resonance.
    Zanier K; Charbonnier S; Baltzinger M; Nominé Y; Altschuh D; Travé G
    J Mol Biol; 2005 Jun; 349(2):401-12. PubMed ID: 15890204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.